HLA-G and ovarian carcinoma: Hence, it is tempting to speculate that HLA-GEV have a larger pool of cells to interact with, potentially explaining the prognostic relevance of HLA-GEV, but not of total sHLA-G, in breast and ovarian cancer patients (20, 21).